HARLOW JOHN B. JR. (Chief Commercial Officer) received a stock award from ESPERION THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/8/2025ACC: 0001628280-25-055842
Officer· Chief Commercial Officer
Since Nov 2025
+804.54K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
804.54K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+424.54K
Price / share
—
Trade value
—
% of position
New position
12/4/2025
0.00→424.54K
Total
Net shares
+424.54K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/4/2025 | A · Award | +424.54K | — | — | New position | 0.00 | 424.54K |
| Total | +424.54K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
380K shares
Shares
+380K
Strike price
3.79
Held after
380K
Exercisable
—
12/4/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock380K shares | 12/4/2025 | A · Award | +380K | 3.79 | — | 380K |